Helius Medical Technologies is trading 7.7% up at $2.82 in after-hours on October 1, 2026, with its recent offering pricing a possible catalyst, not a confirmed cause.
- On September 30, the company announced pricing of a registered direct offering expected to raise about $15 million.
- The offering includes 4,369,356 shares priced at $3.433 each and accompanying warrants; proceeds could support Solana-per-share growth, buybacks, and general corporate purposes.